-
1
-
-
23044501404
-
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
-
DOI 10.1200/JCO.2005.12.516
-
Wierda W., O'Brien S., Wen S., Faderl S., Garcia-Manero G., Thomas D., Do K.-A., Cortes J., Koller C., Beran M., Ferrajoli A., Giles F., Lerner S., Albitar M., Kantarjian H., Keating M., Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia Journal of Clinical Oncology 2005 23 18 4070 4078 (Pubitemid 46211312)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.18
, pp. 4070-4078
-
-
Wierda, W.1
O'Brien, S.2
Wen, S.3
Faderl, S.4
Garcia-Manero, G.5
Thomas, D.6
Do, K.-A.7
Cortes, J.8
Koller, C.9
Beran, M.10
Ferrajoli, A.11
Giles, F.12
Lerner, S.13
Albitar, M.14
Kantarjian, H.15
Keating, M.16
-
2
-
-
33744793781
-
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia
-
DOI 10.1200/JCO.2005.04.6037
-
Montillo M., Tedeschi A., Miqueleiz S., Veronese S., Cairoli R., Intropido L., Ricci F., Colosimo A., Scarpati B., Montagna M., Nichelatti M., Regazzi M., Morra E., Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia Journal of Clinical Oncology 2006 24 15 2337 2342 (Pubitemid 46630666)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.15
, pp. 2337-2342
-
-
Montillo, M.1
Tedeschi, A.2
Miqueleiz, S.3
Veronese, S.4
Cairoli, R.5
Intropido, L.6
Ricci, F.7
Colosimo, A.8
Scarpati, B.9
Montagna, M.10
Nichelatti, M.11
Regazzi, M.12
Morra, E.13
-
3
-
-
31544434508
-
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia
-
DOI 10.1182/blood-2005-06-2395
-
Eichhorst B. F., Busch R., Hopfinger G., Pasold R., Hensel M., Steinbrecher C., Siehl S., Jger U., Bergmann M., Stilgenbauer S., Schweighofer C., Wendtner C. M., Dhner H., Brittinger G., Emmerich B., Hallek M., Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia Blood 2006 107 3 885 891 (Pubitemid 43156283)
-
(2006)
Blood
, vol.107
, Issue.3
, pp. 885-891
-
-
Eichhorst, B.F.1
Busch, R.2
Hopfinger, G.3
Pasold, R.4
Hensel, M.5
Steinbrecher, C.6
Siehl, S.7
Jager, U.8
Bergmann, M.9
Stilgenbauer, S.10
Schweighofer, C.11
Wendtner, C.M.12
Dohner, H.13
Brittinger, G.14
Emmerich, B.15
Hallek, M.16
-
4
-
-
2642551675
-
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: Implications of minimal residual disease measurement with quantitative PCR
-
DOI 10.1182/blood-2003-12-4321
-
Ritgen M., Stilgenbauer S., von Neuhoff N., Humpe A., Brggemann M., Pott C., Raff T., Krber A., Bunjes D., Schlenk R., Schmitz N., Dhner H., Kneba M., Dreger P., Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR Blood 2004 104 8 2600 2602 (Pubitemid 39331866)
-
(2004)
Blood
, vol.104
, Issue.8
, pp. 2600-2602
-
-
Ritgen, M.1
Stilgenbauer, S.2
Von Neuhoff, N.3
Humpe, A.4
Bruggemann, M.5
Pott, C.6
Raff, T.7
Krober, A.8
Bunjes, D.9
Schlenk, R.10
Schmitz, N.11
Dohner, H.12
Kneba, M.13
Dreger, P.14
-
5
-
-
1642292996
-
H gene mutational status
-
DOI 10.1182/blood-2003-05-1549
-
Dreger P., Stilgenbauer S., Benner A., Ritgen M., Krber A., Kneba M., Schmitz N., Dhner H., The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the V H gene mutational status Blood 2004 103 7 2850 2858 (Pubitemid 38393051)
-
(2004)
Blood
, vol.103
, Issue.7
, pp. 2850-2858
-
-
Dreger, P.1
Stilgenbauer, S.2
Benner, A.3
Ritgen, M.4
Krober, A.5
Kneba, M.6
Schmitz, N.7
Dohner, H.8
-
6
-
-
20644447584
-
Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia
-
Moreno C., Villamor N., Colomer D., Esteve J., Martino R., Nomdedéu J., Bosch F., Lpez-Guillermo A., Campo E., Sierra J., Montserrat E., Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia Journal of Clinical Oncology 2005 23 15 3433 3438
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.15
, pp. 3433-3438
-
-
Moreno, C.1
Villamor, N.2
Colomer, D.3
Esteve, J.4
Martino, R.5
Nomdedéu, J.6
Bosch, F.7
Lpez-Guillermo, A.8
Campo, E.9
Sierra, J.10
Montserrat, E.11
-
7
-
-
33748694108
-
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia
-
DOI 10.1182/blood-2006-04-007898
-
Zenz T., Ritgen M., Dreger P., Krber A., Barth T. F., Schlenk R., Bttcher S., Hallek M. J., Kneba M., Bunjes D., Dhner H., Stilgenbauer S., Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia Blood 2006 108 6 2127 2130 (Pubitemid 44395031)
-
(2006)
Blood
, vol.108
, Issue.6
, pp. 2127-2130
-
-
Zenz, T.1
Ritgen, M.2
Dreger, P.3
Krober, A.4
Barth, T.F.5
Schlenk, R.6
Bottcher, S.7
Hallek, M.J.8
Kneba, M.9
Bunjes, D.10
Dohner, H.11
Stilgenbauer, S.12
-
8
-
-
78650007259
-
State of the art treatment of chronic lymphocytic leukaemia
-
Hallek M., Pflug N., State of the art treatment of chronic lymphocytic leukaemia Blood Reviews 2011 25 1 1 9
-
(2011)
Blood Reviews
, vol.25
, Issue.1
, pp. 1-9
-
-
Hallek, M.1
Pflug, N.2
-
9
-
-
41149101246
-
Antibody Therapy for Chronic Lymphocytic Leukemia
-
DOI 10.1053/j.seminhematol.2008.02.001, PII S0037196308000024
-
Christian B. A., Lin T. S., Antibody therapy for chronic lymphocytic leukemia Seminars in Hematology 2008 45 2 95 103 (Pubitemid 351434408)
-
(2008)
Seminars in Hematology
, vol.45
, Issue.2
, pp. 95-103
-
-
Christian, B.A.1
Lin, T.S.2
-
10
-
-
26444566785
-
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia
-
DOI 10.1158/1078-0432.CCR-05-0484
-
Biagi E., Rousseau R., Yvon E., Schwartz M., Dotti G., Foster A., Havlik-Cooper D., Grilley B., Gee A., Baker K., Carrum G., Rice L., Andreeff M., Popat U., Brenner M., Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia Clinical Cancer Research 2005 11 19 6916 6923 (Pubitemid 41428749)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.19
, pp. 6916-6923
-
-
Biagi, E.1
Rousseau, R.2
Yvon, E.3
Schwartz, M.4
Dotti, G.5
Foster, A.6
Havlik-Cooper, D.7
Grilley, B.8
Gee, A.9
Baker, K.10
Carrum, G.11
Rice, L.12
Andreeff, M.13
Popat, U.14
Brenner, M.15
-
11
-
-
0034329352
-
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
-
Wierda W. G., Cantwell M. J., Woods S. J., Rassenti L. Z., Prussak C. E., Kipps T. J., CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia Blood 2000 96 9 2917 2924
-
(2000)
Blood
, vol.96
, Issue.9
, pp. 2917-2924
-
-
Wierda, W.G.1
Cantwell, M.J.2
Woods, S.J.3
Rassenti, L.Z.4
Prussak, C.E.5
Kipps, T.J.6
-
12
-
-
68049102310
-
Development of tumor-reactive T-cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia
-
Nishida T., Hudecek M., Kostic A., Bleakley M., Warren E. H., Maloney D., Storb R., Riddell S. R., Development of tumor-reactive T-cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia Clinical Cancer Research 2009 15 14 4759 4768
-
(2009)
Clinical Cancer Research
, vol.15
, Issue.14
, pp. 4759-4768
-
-
Nishida, T.1
Hudecek, M.2
Kostic, A.3
Bleakley, M.4
Warren, E.H.5
Maloney, D.6
Storb, R.7
Riddell, S.R.8
-
13
-
-
0036570957
-
Tuning tumor-specific T-cell activation: A matter of costimulation?
-
DOI 10.1016/S1471-4906(02)02180-4, PII S1471490602021804
-
Abken H., Hombach A., Heuser C., Kronfeld K., Seliger B., Tuning tumor-specific T-cell activation: a matter of costimulation? Trends in Immunology 2002 23 5 240 245 (Pubitemid 34499560)
-
(2002)
Trends in Immunology
, vol.23
, Issue.5
, pp. 240-245
-
-
Abken, H.1
Hombach, A.2
Heuser, C.3
Kronfeld, K.4
Seliger, B.5
-
14
-
-
0027471898
-
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors
-
DOI 10.1073/pnas.90.2.720
-
Eshhar Z., Waks T., Gross G., Schindler D. G., Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the or subunits of the immunoglobulin and T-cell receptors Proceedings of the National Academy of Sciences of the United States of America 1993 90 2 720 724 (Pubitemid 23028937)
-
(1993)
Proceedings of the National Academy of Sciences of the United States of America
, vol.90
, Issue.2
, pp. 720-724
-
-
Eshhar, Z.1
Waks, T.2
Gross, G.3
Schindler, D.G.4
-
15
-
-
0036635506
-
T-cell-receptor gene therapy
-
Schumacher T. N. M., T-cell-receptor gene therapy Nature Reviews Immunology 2002 2 7 512 519 (Pubitemid 37328742)
-
(2002)
Nature Reviews Immunology
, vol.2
, Issue.7
, pp. 512-519
-
-
Schumacher, T.N.M.1
-
16
-
-
0024834988
-
Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity
-
DOI 10.1073/pnas.86.24.10024
-
Gross G., Waks T., Eshhar Z., Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proceedings of the National Academy of Sciences of the United States of America 1989 86 24 10024 10028 (Pubitemid 20030768)
-
(1989)
Proceedings of the National Academy of Sciences of the United States of America
, vol.86
, Issue.24
, pp. 10024-10028
-
-
Gross, G.1
Waks, T.2
Eshhar, Z.3
-
17
-
-
0029891157
-
Qualitative and quantitative contributions of the T cell receptor ζ chain to mature T cell apoptosis
-
DOI 10.1084/jem.183.5.2109
-
Combadire B., Freedman M., Chen L., Shores E. W., Love P., Lenardo M. J., Qualitative and quantitative contributions of the T-cell receptor chain to mature T-cell apoptosis Journal of Experimental Medicine 1996 183 5 2109 2117 (Pubitemid 26158903)
-
(1996)
Journal of Experimental Medicine
, vol.183
, Issue.5
, pp. 2109-2117
-
-
Combadiere, B.1
Freedman, M.2
Chen, L.3
Shores, E.W.4
Love, P.5
Lenardo, M.J.6
-
18
-
-
77957756405
-
Adoptive transfer of syngeneic T-cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B-cells
-
Kochenderfer J. N., Yu Z., Frasheri D., Restifo N. P., Rosenberg S. A., Adoptive transfer of syngeneic T-cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B-cells Blood 2010 116 19 3875 3886
-
(2010)
Blood
, vol.116
, Issue.19
, pp. 3875-3886
-
-
Kochenderfer, J.N.1
Yu, Z.2
Frasheri, D.3
Restifo, N.P.4
Rosenberg, S.A.5
-
19
-
-
76749120309
-
A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity
-
Zhao Y., Wang Q. J., Yang S., Kochenderfer J. N., Zheng Z., Zhong X., Sadelain M., Eshhar Z., Rosenberg S. A., Morgan R. A., A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity Journal of Immunology 2009 183 9 5563 5574
-
(2009)
Journal of Immunology
, vol.183
, Issue.9
, pp. 5563-5574
-
-
Zhao, Y.1
Wang, Q.J.2
Yang, S.3
Kochenderfer, J.N.4
Zheng, Z.5
Zhong, X.6
Sadelain, M.7
Eshhar, Z.8
Rosenberg, S.A.9
Morgan, R.A.10
-
20
-
-
51049104493
-
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts
-
Klechevsky E., Gallegos M., Denkberg G., Palucka K., Banchereau J., Cohen C., Reiter Y., Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts Cancer Research 2008 68 15 6360 6367
-
(2008)
Cancer Research
, vol.68
, Issue.15
, pp. 6360-6367
-
-
Klechevsky, E.1
Gallegos, M.2
Denkberg, G.3
Palucka, K.4
Banchereau, J.5
Cohen, C.6
Reiter, Y.7
-
21
-
-
20444377728
-
T cell retargeting with MHC class I-restricted antibodies: The CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production
-
Willemsen R. A., Ronteltap C., Chames P., Debets R., Bolhuis R. L. H., T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production Journal of Immunology 2005 174 12 7853 7858 (Pubitemid 40806294)
-
(2005)
Journal of Immunology
, vol.174
, Issue.12
, pp. 7853-7858
-
-
Willemsen, R.A.1
Ronteltap, C.2
Chames, P.3
Debets, R.4
Bolhuis, R.L.H.5
-
22
-
-
65249176824
-
Rational development of high-affinity T-cell receptor-like antibodies
-
Stewart-Jones G., Wadle A., Hombach A., Shenderov E., Held G., Fischer E., Kleber S., Stenner-Liewen F., Bauer S., McMichael A., Knuth A., Abken H., Hombach A. A., Cerundolo V., Jones E. Y., Renner C., Rational development of high-affinity T-cell receptor-like antibodies Proceedings of the National Academy of Sciences of the United States of America 2009 106 14 5784 5788
-
(2009)
Proceedings of the National Academy of Sciences of the United States of America
, vol.106
, Issue.14
, pp. 5784-5788
-
-
Stewart-Jones, G.1
Wadle, A.2
Hombach, A.3
Shenderov, E.4
Held, G.5
Fischer, E.6
Kleber, S.7
Stenner-Liewen, F.8
Bauer, S.9
McMichael, A.10
Knuth, A.11
Abken, H.12
Hombach, A.A.13
Cerundolo, V.14
Jones, E.Y.15
Renner, C.16
-
23
-
-
78649461928
-
The B-cell tumor-associated antigen ROR1 can be targeted with T-cells modified to express a ROR1-specific chimeric antigen receptor
-
Hudecek M., Schmitt T. M., Baskar S., Lupo-Stanghellini M. T., Nishida T., Yamamoto T. N., Bleakley M., Turtle C. J., Chang W. C., Greisman H. A., Wood B., Maloney D. G., Jensen M. C., Rader C., Riddell S. R., The B-cell tumor-associated antigen ROR1 can be targeted with T-cells modified to express a ROR1-specific chimeric antigen receptor Blood 2010 116 22 4532 4541
-
(2010)
Blood
, vol.116
, Issue.22
, pp. 4532-4541
-
-
Hudecek, M.1
Schmitt, T.M.2
Baskar, S.3
Lupo-Stanghellini, M.T.4
Nishida, T.5
Yamamoto, T.N.6
Bleakley, M.7
Turtle, C.J.8
Chang, W.C.9
Greisman, H.A.10
Wood, B.11
Maloney, D.G.12
Jensen, M.C.13
Rader, C.14
Riddell, S.R.15
-
24
-
-
0029163387
-
CD28 costimulation can promote T-cell survival by enhancing the expression of Bcl-x L
-
Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B., CD28 costimulation can promote T-cell survival by enhancing the expression of Bcl-x L Immunity 1995 3 1 87 98
-
(1995)
Immunity
, vol.3
, Issue.1
, pp. 87-98
-
-
Boise, L.H.1
Minn, A.J.2
Noel, P.J.3
June, C.H.4
Accavitti, M.A.5
Lindsten, T.6
Thompson, C.B.7
-
25
-
-
0032531091
-
Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product
-
Finney H. M., Lawson A. D. G., Bebbington C. R., Weir A. N. C., Chimeric receptors providing both primary and costimulatory signaling in T-cells from a single gene product Journal of Immunology 1998 161 6 2791 2797 (Pubitemid 28425698)
-
(1998)
Journal of Immunology
, vol.161
, Issue.6
, pp. 2791-2797
-
-
Finney, H.M.1
Lawson, A.D.G.2
Bebbington, C.R.3
Weir, A.N.C.4
-
26
-
-
0035576250
-
Tumor-specific T cell activation by recombinant immunoreceptors: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3ζ signaling receptor molecule
-
Hombach A., Wieczarkowiecz A., Marquardt T., Heuser C., Usai L., Pohl C., Seliger B., Abken H., Tumor-specific T-cell activation by recombinant immunoreceptors: CD3 signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 signaling receptor molecule Journal of Immunology 2001 167 11 6123 6131 (Pubitemid 33081538)
-
(2001)
Journal of Immunology
, vol.167
, Issue.11
, pp. 6123-6131
-
-
Hombach, A.1
Wieczarkowiecz, A.2
Marquardt, T.3
Heuser, C.4
Usai, L.5
Pohl, C.6
Seliger, B.7
Abken, H.8
-
27
-
-
33847367680
-
Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy
-
DOI 10.1007/s00262-006-0249-0
-
Hombach A., Abken H., Costimulation tunes tumor-specific activation of redirected T-cells in adoptive immunotherapy Cancer Immunology, Immunotherapy 2007 56 5 731 737 (Pubitemid 46348741)
-
(2007)
Cancer Immunology, Immunotherapy
, vol.56
, Issue.5
, pp. 731-737
-
-
Hombach, A.1
Abken, H.2
-
28
-
-
84855186143
-
Costimulation by chimeric antigen receptors revisited: The T-cell antitumor response benefits from combined CD28-OX40 signalling
-
In press
-
Hombach A. A., Abken H., Costimulation by chimeric antigen receptors revisited: the T-cell antitumor response benefits from combined CD28-OX40 signalling. International Journal of Cancer. In press
-
International Journal of Cancer
-
-
Hombach, A.A.1
Abken, H.2
-
29
-
-
0035266137
-
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis
-
Hombach A., Sent D., Schneider C., Heuser C., Koch D., Pohl C., Seliger B., Abken H., T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis Cancer Research 2001 61 5 1976 1982 (Pubitemid 32692016)
-
(2001)
Cancer Research
, vol.61
, Issue.5
, pp. 1976-1982
-
-
Hombach, A.1
Sent, D.2
Schneider, C.3
Heuser, C.4
Koch, D.5
Pohl, C.6
Seliger, B.7
Abken, H.8
-
30
-
-
33746145652
-
A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3ζ-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells
-
DOI 10.1136/gut.2005.076208
-
Hombach A., Schlimper C., Sievers E., Frank S., Schild H. H., Sauerbruch T., Schmidt-Wolf I. G. H., Abken H., A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3 -CD28 signalling targets T-cells from colorectal cancer patients against their tumour cells Gut 2006 55 8 1156 1164 (Pubitemid 44085685)
-
(2006)
Gut
, vol.55
, Issue.8
, pp. 1156-1164
-
-
Hombach, A.1
Schlimper, C.2
Sievers, E.3
Frank, S.4
Schild, H.H.5
Sauerbruch, T.6
Schmidt-Wolf, I.G.H.7
Abken, H.8
-
31
-
-
62549097817
-
Control of large, established tumor xenografts with genetically retargeted human T-cells containing CD28 and CD137 domains
-
Carpenito C., Milone M. C., Hassan R., Simonet J. C., Lakhal M., Suhoski M. M., Varela-Rohena A., Haines K. M., Heitjan D. F., Albelda S. M., Carroll R. G., Riley J. L., Pastan I., June C. H., Control of large, established tumor xenografts with genetically retargeted human T-cells containing CD28 and CD137 domains Proceedings of the National Academy of Sciences of the United States of America 2009 106 9 3360 3365
-
(2009)
Proceedings of the National Academy of Sciences of the United States of America
, vol.106
, Issue.9
, pp. 3360-3365
-
-
Carpenito, C.1
Milone, M.C.2
Hassan, R.3
Simonet, J.C.4
Lakhal, M.5
Suhoski, M.M.6
Varela-Rohena, A.7
Haines, K.M.8
Heitjan, D.F.9
Albelda, S.M.10
Carroll, R.G.11
Riley, J.L.12
Pastan, I.13
June, C.H.14
-
32
-
-
70350726110
-
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T-cells and increased antileukemic efficacy in vivo
-
Milone M. C., Fish J. D., Carpenito C., Carroll R. G., Binder G. K., Teachey D., Samanta M., Lakhal M., Gloss B., Danet-Desnoyers G., Campana D., Riley J. L., Grupp S. A., June C. H., Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T-cells and increased antileukemic efficacy in vivo Molecular Therapy 2009 17 8 1453 1464
-
(2009)
Molecular Therapy
, vol.17
, Issue.8
, pp. 1453-1464
-
-
Milone, M.C.1
Fish, J.D.2
Carpenito, C.3
Carroll, R.G.4
Binder, G.K.5
Teachey, D.6
Samanta, M.7
Lakhal, M.8
Gloss, B.9
Danet-Desnoyers, G.10
Campana, D.11
Riley, J.L.12
Grupp, S.A.13
June, C.H.14
-
33
-
-
33947203783
-
+ T cells in an antitumor cell attack
-
DOI 10.1158/0008-5472.CAN-06-2098
-
Koehler H., Kofler D., Hombach A., Abken H., CD28 costimulation overcomes transforming growth factor- -mediated repression of proliferation of redirected human CD4 + and CD8 + T-cells in an antitumor cell attack Cancer Research 2007 67 5 2265 2273 (Pubitemid 46424246)
-
(2007)
Cancer Research
, vol.67
, Issue.5
, pp. 2265-2273
-
-
Koehler, H.1
Kofler, D.2
Hombach, A.3
Abken, H.4
-
34
-
-
79954573204
-
In vivo inhibition of human CD19-targeted effector T-cells by natural T regulatory cells in a xenotransplant murine model of B-cell malignancy
-
Lee J. C., Hayman E., Pegram H. J., Santos E., Heller G., Sadelain M., Brentjens R., In vivo inhibition of human CD19-targeted effector T-cells by natural T regulatory cells in a xenotransplant murine model of B-cell malignancy Cancer Research 2011 71 8 2871 2881
-
(2011)
Cancer Research
, vol.71
, Issue.8
, pp. 2871-2881
-
-
Lee, J.C.1
Hayman, E.2
Pegram, H.J.3
Santos, E.4
Heller, G.5
Sadelain, M.6
Brentjens, R.7
-
35
-
-
79953320804
-
CD28 costimulation impairs the efficacy of a redirected T-cell antitumor attack in the presence of regulatory T-cells which can be overcome by preventing lck activation
-
Kofler D. M., Chmielewski M., Rappl G., Hombach A., Riet T., Schmidt A., Hombach A. A., Wendtner C.-M., Abken H., CD28 costimulation impairs the efficacy of a redirected T-cell antitumor attack in the presence of regulatory T-cells which can be overcome by preventing lck activation Molecular Therapy 2011 19 4 760 767
-
(2011)
Molecular Therapy
, vol.19
, Issue.4
, pp. 760-767
-
-
Kofler, D.M.1
Chmielewski, M.2
Rappl, G.3
Hombach, A.4
Riet, T.5
Schmidt, A.6
Hombach, A.A.7
Wendtner, C.-M.8
Abken, H.9
-
36
-
-
0037348324
-
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
-
DOI 10.1038/nm827
-
Brentjens R. J., Latouche J. B., Santos E., Marti F., Gong M. C., Lyddane C., King P. D., Larson S., Weiss M., Rivire I., Sadelain M., Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 Nature Medicine 2003 9 3 279 286 (Pubitemid 36362782)
-
(2003)
Nature Medicine
, vol.9
, Issue.3
, pp. 279-286
-
-
Brentjens, R.J.1
Latouche, J.-B.2
Santos, E.3
Marti, F.4
Gong, M.C.5
Lyddane, C.6
King, P.D.7
Larson, S.8
Weiss, M.9
Riviere, I.10
Sadelain, M.11
-
37
-
-
0033106396
-
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia
-
Hallek M., Langenmayer I., Nerl C., Knauf W., Dietzfelbinger H., Adorf D., Ostwald M., Busch R., Kuhn-Hallek I., Thiel E., Emmerich B., Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia Blood 1999 93 5 1732 1737 (Pubitemid 29102502)
-
(1999)
Blood
, vol.93
, Issue.5
, pp. 1732-1737
-
-
Hallek, M.1
Langenmayer, I.2
Nerl, C.3
Knauf, W.4
Dietzfelbinger, H.5
Adorf, D.6
Ostwald, M.7
Busch, R.8
Kuhn-Hallek, I.9
Thiel, E.10
Emmerich, B.11
-
38
-
-
0347986676
-
Mitotic Degradation of Human Thymidine Kinase 1 Is Dependent on the Anaphase-Promoting Complex/Cyclosome - Cdh1-Mediated Pathway
-
DOI 10.1128/MCB.24.2.514-526.2004
-
Ke P.-Y., Chang Z.-F., Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosomeCdh1-mediated pathway Molecular and Cellular Biology 2004 24 2 514 526 (Pubitemid 38057905)
-
(2004)
Molecular and Cellular Biology
, vol.24
, Issue.2
, pp. 514-526
-
-
Ke, P.-Y.1
Chang, Z.-F.2
-
39
-
-
79952100710
-
Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease
-
D'Arena G., Laurenti L., Minervini M. M., Deaglio S., Bonello L., De Martino L., De Padua L., Savino L., Tarnani M., De Feo V., Cascavilla N., Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease Leukemia Research 2011 35 3 363 368
-
(2011)
Leukemia Research
, vol.35
, Issue.3
, pp. 363-368
-
-
D'Arena, G.1
Laurenti, L.2
Minervini, M.M.3
Deaglio, S.4
Bonello, L.5
De Martino, L.6
De Padua, L.7
Savino, L.8
Tarnani, M.9
De Feo, V.10
Cascavilla, N.11
-
40
-
-
33845294816
-
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
-
DOI 10.1158/0008-5472.CAN-06-0160
-
Kowolik C. M., Topp M. S., Gonzalez S., Pfeiffer T., Olivares S., Gonzalez N., Smith D. D., Forman S. J., Jensen M. C., Cooper L. J. N., CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T-cells Cancer Research 2006 66 22 10995 11004 (Pubitemid 44876999)
-
(2006)
Cancer Research
, vol.66
, Issue.22
, pp. 10995-11004
-
-
Kowolik, C.M.1
Topp, M.S.2
Gonzalez, S.3
Pfeiffer, T.4
Olivares, S.5
Gonzalez, N.6
Smith, D.D.7
Forman, S.J.8
Jensen, M.C.9
Cooper, L.J.N.10
-
41
-
-
70350726110
-
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T-cells and increased antileukemic efficacy in vivo
-
Milone M. C., Fish J. D., Carpenito C., Carroll R. G., Binder G. K., Teachey D., Samanta M., Lakhal M., Gloss B., Danet-Desnoyers G., Campana D., Riley J. L., Grupp S. A., June C. H., Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T-cells and increased antileukemic efficacy in vivo Molecular Therapy 2009 17 8 1453 1464
-
(2009)
Molecular Therapy
, vol.17
, Issue.8
, pp. 1453-1464
-
-
Milone, M.C.1
Fish, J.D.2
Carpenito, C.3
Carroll, R.G.4
Binder, G.K.5
Teachey, D.6
Samanta, M.7
Lakhal, M.8
Gloss, B.9
Danet-Desnoyers, G.10
Campana, D.11
Riley, J.L.12
Grupp, S.A.13
June, C.H.14
-
42
-
-
78549278144
-
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T-cells genetically engineered to recognize CD19
-
Kochenderfer J. N., Wilson W. H., Janik J. E., Dudley M. E., Stetler-Stevenson M., Feldman S. A., Maric I., Raffeld M., Nathan D. A. N., Lanier B. J., Morgan R. A., Rosenberg S. A., Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T-cells genetically engineered to recognize CD19 Blood 2010 116 20 4099 4102
-
(2010)
Blood
, vol.116
, Issue.20
, pp. 4099-4102
-
-
Kochenderfer, J.N.1
Wilson, W.H.2
Janik, J.E.3
Dudley, M.E.4
Stetler-Stevenson, M.5
Feldman, S.A.6
Maric, I.7
Raffeld, M.8
Nathan, D.A.N.9
Lanier, B.J.10
Morgan, R.A.11
Rosenberg, S.A.12
-
43
-
-
77949891071
-
Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T-cells
-
Cheadle E. J., Hawkins R. E., Batha H., O'Neill A. L., Dovedi S. J., Gilham D. E., Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T-cells Journal of Immunology 2010 184 4 1885 1896
-
(2010)
Journal of Immunology
, vol.184
, Issue.4
, pp. 1885-1896
-
-
Cheadle, E.J.1
Hawkins, R.E.2
Batha, H.3
O'Neill, A.L.4
Dovedi, S.J.5
Gilham, D.E.6
-
44
-
-
0041419656
-
+ T cells
-
DOI 10.1084/jem.20030590
-
Overwijk W. W., Theoret M. R., Finkelstein S. E., Surman D. R., De Jong L. A., Vyth-Dreese F. A., Dellemijn T. A., Antony P. A., Spiess P. J., Palmer D. C., Heimann D. M., Klebanoff C. A., Yu Z., Hwang L. N., Feigenbaum L., Kruisbeek A. M., Rosenberg S. A., Restifo N. P., Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8 + T-cells Journal of Experimental Medicine 2003 198 4 569 580 (Pubitemid 37040391)
-
(2003)
Journal of Experimental Medicine
, vol.198
, Issue.4
, pp. 569-580
-
-
Overwijk, W.W.1
Theoret, M.R.2
Finkelstein, S.E.3
Surman, D.R.4
De Jong, L.A.5
Vyth-Dreese, F.A.6
Dellemijn, T.A.7
Antony, P.A.8
Spiess, P.J.9
Palmer, D.C.10
Heimann, D.M.11
Klebanoff, C.A.12
Yu, Z.13
Hwang, L.N.14
Feigenbaum, L.15
Kruisbeek, A.M.16
Rosenberg, S.A.17
Restifo, N.P.18
-
45
-
-
25844484607
-
+ T cells
-
DOI 10.1084/jem.20050732
-
Gattinoni L., Finkelstein S. E., Klebanoff C. A., Antony P. A., Palmer D. C., Spiess P. J., Hwang L. N., Yu Z., Wrzesinski C., Heimann D. M., Surh C. D., Rosenberg S. A., Restifo N. P., Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T-cells Journal of Experimental Medicine 2005 202 7 907 912 (Pubitemid 41396891)
-
(2005)
Journal of Experimental Medicine
, vol.202
, Issue.7
, pp. 907-912
-
-
Gattinoni, L.1
Finkelstein, S.E.2
Klebanoff, C.A.3
Antony, P.A.4
Palmer, D.C.5
Spiess, P.J.6
Hwang, L.N.7
Yu, Z.8
Wrzesinski, C.9
Heimann, D.M.10
Surh, C.D.11
Rosenberg, S.A.12
Restifo, N.P.13
-
46
-
-
55949125601
-
Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens
-
Dudley M. E., Yang J. C., Sherry R., Hughes M. S., Royal R., Kammula U., Robbins P. F., Huang J., Citrin D. E., Leitman S. F., Wunderlich J., Restifo N. P., Thomasian A., Downey S. G., Smith F. O., Klapper J., Morton K., Laurencot C., White D. E., Rosenberg S. A., Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens Journal of Clinical Oncology 2008 26 32 5233 5239
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.32
, pp. 5233-5239
-
-
Dudley, M.E.1
Yang, J.C.2
Sherry, R.3
Hughes, M.S.4
Royal, R.5
Kammula, U.6
Robbins, P.F.7
Huang, J.8
Citrin, D.E.9
Leitman, S.F.10
Wunderlich, J.11
Restifo, N.P.12
Thomasian, A.13
Downey, S.G.14
Smith, F.O.15
Klapper, J.16
Morton, K.17
Laurencot, C.18
White, D.E.19
Rosenberg, S.A.20
more..
-
47
-
-
70449726875
-
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
-
Cui Y., Zhang H., Meadors J., Poon R., Guimond M., Mackall C. L., Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts Blood 2009 114 18 3831 3840
-
(2009)
Blood
, vol.114
, Issue.18
, pp. 3831-3840
-
-
Cui, Y.1
Zhang, H.2
Meadors, J.3
Poon, R.4
Guimond, M.5
MacKall, C.L.6
-
48
-
-
67650360757
-
Rapid immune recovery and graft-versus-host diseaselike engraftment syndrome following adoptive transfer of costimulated autologous T-cells
-
Rapoport A. P., Stadtmauer E. A., Aqui N., Vogl D., Chew A., Fang H.-B., Janofsky S., Yager K., Veloso E., Zheng Z., Milliron T., Westphal S., Cotte J., Huynh H., Cannon A., Yanovich S., Akpek G., Tan M., Virts K., Ruehle K., Harris C., Philip S., Vonderheide R. H., Levine B. L., June C. H., Rapid immune recovery and graft-versus-host diseaselike engraftment syndrome following adoptive transfer of costimulated autologous T-cells Clinical Cancer Research 2009 15 13 4499 4507
-
(2009)
Clinical Cancer Research
, vol.15
, Issue.13
, pp. 4499-4507
-
-
Rapoport, A.P.1
Stadtmauer, E.A.2
Aqui, N.3
Vogl, D.4
Chew, A.5
Fang, H.-B.6
Janofsky, S.7
Yager, K.8
Veloso, E.9
Zheng, Z.10
Milliron, T.11
Westphal, S.12
Cotte, J.13
Huynh, H.14
Cannon, A.15
Yanovich, S.16
Akpek, G.17
Tan, M.18
Virts, K.19
Ruehle, K.20
Harris, C.21
Philip, S.22
Vonderheide, R.H.23
Levine, B.L.24
June, C.H.25
more..
-
49
-
-
79952146504
-
CARs on track in the clinic
-
Kohn D. B., Dotti G., Brentjens R., Savoldo B., Jensen M., Cooper L. J.N., June C. H., Rosenberg S., Sadelain M., Heslop H. E., CARs on track in the clinic Molecular Therapy 2011 19 3 432 438
-
(2011)
Molecular Therapy
, vol.19
, Issue.3
, pp. 432-438
-
-
Kohn, D.B.1
Dotti, G.2
Brentjens, R.3
Savoldo, B.4
Jensen, M.5
Cooper, L.J.N.6
June, C.H.7
Rosenberg, S.8
Sadelain, M.9
Heslop, H.E.10
-
50
-
-
74349084455
-
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T-cells
-
Wrzesinski C., Paulos C. M., Kaiser A., Muranski P., Palmer D. C., Gattinoni L., Yu Z., Rosenberg S. A., Restifo N. P., Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T-cells Journal of Immunotherapy 2010 33 1 1 7
-
(2010)
Journal of Immunotherapy
, vol.33
, Issue.1
, pp. 1-7
-
-
Wrzesinski, C.1
Paulos, C.M.2
Kaiser, A.3
Muranski, P.4
Palmer, D.C.5
Gattinoni, L.6
Yu, Z.7
Rosenberg, S.A.8
Restifo, N.P.9
-
51
-
-
63649112916
-
Manufacturing validation of biologically functional T-cells targeted to CD19 antigen for autologous adoptive cell therapy
-
Hollyman D., Stefanski J., Przybylowski M., Bartido S., Borquez-Ojeda O., Taylor C., Yeh R., Capacio V., Olszewska M., Hosey J., Sadelain M., Brentjens R. J., Rivire I., Manufacturing validation of biologically functional T-cells targeted to CD19 antigen for autologous adoptive cell therapy Journal of Immunotherapy 2009 32 2 169 180
-
(2009)
Journal of Immunotherapy
, vol.32
, Issue.2
, pp. 169-180
-
-
Hollyman, D.1
Stefanski, J.2
Przybylowski, M.3
Bartido, S.4
Borquez-Ojeda, O.5
Taylor, C.6
Yeh, R.7
Capacio, V.8
Olszewska, M.9
Hosey, J.10
Sadelain, M.11
Brentjens, R.J.12
Rivire, I.13
-
52
-
-
34547775694
-
Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: An approach to improving product safety, composition, and production capacity
-
DOI 10.1097/CJI.0b013e318052e1f4, PII 0000237120070900000008
-
Tran C.-A., Burton L., Russom D., Wagner J. R., Jensen M. C., Forman S. J., DiGiusto D. L., Manufacturing of large numbers of patient-specific T-cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity Journal of Immunotherapy 2007 30 6 644 654 (Pubitemid 47229699)
-
(2007)
Journal of Immunotherapy
, vol.30
, Issue.6
, pp. 644-654
-
-
Tran, C.-A.1
Burton, L.2
Russom, D.3
Wagner, J.R.4
Jensen, M.C.5
Forman, S.J.6
DiGiusto, D.L.7
-
53
-
-
77950480974
-
Treatment of chronic lymphocytic leukemia with genetically targeted autologous T-cells: Case report of an unforeseen adverse event in a phase i clinical trial
-
Brentjens R., Yeh R., Bernal Y., Riviere I., Sadelain M., Treatment of chronic lymphocytic leukemia with genetically targeted autologous T-cells: case report of an unforeseen adverse event in a phase i clinical trial Molecular Therapy 2010 18 4 666 668
-
(2010)
Molecular Therapy
, vol.18
, Issue.4
, pp. 666-668
-
-
Brentjens, R.1
Yeh, R.2
Bernal, Y.3
Riviere, I.4
Sadelain, M.5
-
54
-
-
55549145071
-
Virus-specific T-cells engineered to coexpress tumor-specific receptors: Persistence and antitumor activity in individuals with neuroblastoma
-
Pule M. A., Savoldo B., Myers G. D., Rossig C., Russell H. V., Dotti G., Huls M. H., Liu E., Gee A. P., Mei Z., Yvon E., Weiss H. L., Liu H., Rooney C. M., Heslop H. E., Brenner M. K., Virus-specific T-cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma Nature Medicine 2008 14 11 1264 1270
-
(2008)
Nature Medicine
, vol.14
, Issue.11
, pp. 1264-1270
-
-
Pule, M.A.1
Savoldo, B.2
Myers, G.D.3
Rossig, C.4
Russell, H.V.5
Dotti, G.6
Huls, M.H.7
Liu, E.8
Gee, A.P.9
Mei, Z.10
Yvon, E.11
Weiss, H.L.12
Liu, H.13
Rooney, C.M.14
Heslop, H.E.15
Brenner, M.K.16
-
55
-
-
34250365425
-
+ T cells
-
DOI 10.1016/j.exphem.2007.04.007, PII S0301472X07002500
-
Numbenjapon T., Serrano L. M., Chang W.-C., Forman S. J., Jensen M. C., Cooper L. J. N., Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8 + T-cells Experimental Hematology 2007 35 7 1083 1090 (Pubitemid 46921316)
-
(2007)
Experimental Hematology
, vol.35
, Issue.7
, pp. 1083-1090
-
-
Numbenjapon, T.1
Serrano, L.M.2
Chang, W.-C.3
Forman, S.J.4
Jensen, M.C.5
Cooper, L.J.N.6
-
56
-
-
70349283020
-
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma
-
Huarte E., Fisher J., Turk M. J., Mellinger D., Foster C., Wolf B., Meehan K. R., Fadul C. E., Ernstoff M. S., Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma Cancer Letters 2009 285 1 80 88
-
(2009)
Cancer Letters
, vol.285
, Issue.1
, pp. 80-88
-
-
Huarte, E.1
Fisher, J.2
Turk, M.J.3
Mellinger, D.4
Foster, C.5
Wolf, B.6
Meehan, K.R.7
Fadul, C.E.8
Ernstoff, M.S.9
-
57
-
-
50549096284
-
Adoptive immunotherapy for indolent non-hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T-cells
-
Till B. G., Jensen M. C., Wang J., Chen E. Y., Wood B. L., Greisman H. A., Qian X., James S. E., Raubitschek A., Forman S. J., Gopal A. K., Pagel J. M., Lindgren C. G., Greenberg P. D., Riddell S. R., Press O. W., Adoptive immunotherapy for indolent non-hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T-cells Blood 2008 112 6 2261 2271
-
(2008)
Blood
, vol.112
, Issue.6
, pp. 2261-2271
-
-
Till, B.G.1
Jensen, M.C.2
Wang, J.3
Chen, E.Y.4
Wood, B.L.5
Greisman, H.A.6
Qian, X.7
James, S.E.8
Raubitschek, A.9
Forman, S.J.10
Gopal, A.K.11
Pagel, J.M.12
Lindgren, C.G.13
Greenberg, P.D.14
Riddell, S.R.15
Press, O.W.16
-
58
-
-
77950961198
-
Building better chimeric antigen receptors for adoptive T-cell therapy
-
Bridgeman J. S., Hawkins R. E., Hombach A. A., Abken H., Gilham D. E., Building better chimeric antigen receptors for adoptive T-cell therapy Current Gene Therapy 2010 10 2 77 90
-
(2010)
Current Gene Therapy
, vol.10
, Issue.2
, pp. 77-90
-
-
Bridgeman, J.S.1
Hawkins, R.E.2
Hombach, A.A.3
Abken, H.4
Gilham, D.E.5
-
59
-
-
34848818523
-
Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo
-
DOI 10.1007/s00262-007-0330-3
-
Lamers C. H. J., Langeveld S. C. L., Ruijven C. M. G., Debets R., Sleijfer S., Gratama J. W., Gene-modified T-cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo Cancer Immunology, Immunotherapy 2007 56 12 1875 1883 (Pubitemid 47512609)
-
(2007)
Cancer Immunology, Immunotherapy
, vol.56
, Issue.12
, pp. 1875-1883
-
-
Lamers, C.H.J.1
Langeveld, S.C.L.2
Groot-Van Ruijven, C.M.3
Debets, R.4
Sleijfer, S.5
Gratama, J.W.6
-
60
-
-
78650969008
-
Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T-cells
-
Lamers C. H. J., Willemsen R., van Elzakker P., Van Steenbergen-Langeveld S., Broertjes M., Oosterwijk-Wakka J., Oosterwijk E., Sleijfer S., Debets R., Gratama J. W., Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T-cells Blood 2011 117 1 72 82
-
(2011)
Blood
, vol.117
, Issue.1
, pp. 72-82
-
-
Lamers, C.H.J.1
Willemsen, R.2
Van Elzakker, P.3
Van Steenbergen-Langeveld, S.4
Broertjes, M.5
Oosterwijk-Wakka, J.6
Oosterwijk, E.7
Sleijfer, S.8
Debets, R.9
Gratama, J.W.10
-
61
-
-
77957980319
-
Adoptive immunotherapy with genetically engineered T-cells: Modification of the IgG1 Fc spacer domain in the extracellular moiety of chimeric antigen receptors avoids off-target activation and unintended initiation of an innate immune response
-
Hombach A., Hombach A. A., Abken H., Adoptive immunotherapy with genetically engineered T-cells: modification of the IgG1 Fc spacer domain in the extracellular moiety of chimeric antigen receptors avoids off-target activation and unintended initiation of an innate immune response Gene Therapy 2010 17 10 1206 1213
-
(2010)
Gene Therapy
, vol.17
, Issue.10
, pp. 1206-1213
-
-
Hombach, A.1
Hombach, A.A.2
Abken, H.3
-
62
-
-
68449088813
-
Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor
-
Kochenderfer J. N., Feldman S. A., Zhao Y., Xu H., Black M. A., Morgan R. A., Wilson W. H., Rosenberg S. A., Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor Journal of Immunotherapy 2009 32 7 689 702
-
(2009)
Journal of Immunotherapy
, vol.32
, Issue.7
, pp. 689-702
-
-
Kochenderfer, J.N.1
Feldman, S.A.2
Zhao, Y.3
Xu, H.4
Black, M.A.5
Morgan, R.A.6
Wilson, W.H.7
Rosenberg, S.A.8
-
63
-
-
15244358572
-
Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes
-
DOI 10.1172/JCI200422284
-
Pinthus J. H., Waks T., Malina V., Kaufman-Francis K., Harmelin A., Aizenberg I., Kanety H., Ramon J., Eshhar Z., Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes Journal of Clinical Investigation 2004 114 12 1774 1781 (Pubitemid 40385533)
-
(2004)
Journal of Clinical Investigation
, vol.114
, Issue.12
, pp. 1774-1781
-
-
Pinthus, J.H.1
Waks, T.2
Malina, V.3
Kaufman-Francis, K.4
Harmelin, A.5
Aizenberg, I.6
Kanety, H.7
Ramon, J.8
Eshhar, Z.9
-
64
-
-
22144437688
-
+ T cells confer superior antitumor immunity compared with effector memory T cells
-
DOI 10.1073/pnas.0503726102
-
Klebanoff C. A., Gattinoni L., Torabi-Parizi P., Kerstann K., Cardones A. R., Finkelstein S. E., Palmer D. C., Antony P. A., Hwang S. T., Rosenberg S. A., Waldmann T. A., Restifo N. P., Central memory self/tumor-reactive CD8 + T-cells confer superior antitumor immunity compared with effector memory T-cells Proceedings of the National Academy of Sciences of the United States of America 2005 102 27 9571 9576 (Pubitemid 40981722)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.27
, pp. 9571-9576
-
-
Klebanoff, C.A.1
Gattinoni, L.2
Torabi-Parizi, P.3
Kerstann, K.4
Cardones, A.R.5
Finkelstein, S.E.6
Palmer, D.C.7
Antony, P.A.8
Hwang, S.T.9
Rosenberg, S.A.10
Waldmann, T.A.11
Restifo, N.P.12
-
65
-
-
38149117105
-
Adoptive transfer of effector CD8 + T-cells derived from central memory cells establishes persistent T-cell memory in primates
-
Berger C., Jensen M. C., Lansdorp P. M., Gough M., Elliott C., Riddell S. R., Adoptive transfer of effector CD8 + T-cells derived from central memory cells establishes persistent T-cell memory in primates Journal of Clinical Investigation 2008 118 1 294 305
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.1
, pp. 294-305
-
-
Berger, C.1
Jensen, M.C.2
Lansdorp, P.M.3
Gough, M.4
Elliott, C.5
Riddell, S.R.6
-
66
-
-
60849098427
-
IL-7 and IL-15 allow the generation of suicide gene modified alloreactive self-renewing central memory human T lymphocytes
-
Kaneko S., Mastaglio S., Bondanza A., Ponzoni M., Sanvito F., Aldrighetti L., Radrizzani M., Simona La S. C., Provasi E., Mondino A., Nagasawa T., Fleischhauer K., Russo V., Traversari C., Ciceri F., Bordignon C., Bonini C., IL-7 and IL-15 allow the generation of suicide gene modified alloreactive self-renewing central memory human T lymphocytes Blood 2009 113 5 1006 1015
-
(2009)
Blood
, vol.113
, Issue.5
, pp. 1006-1015
-
-
Kaneko, S.1
Mastaglio, S.2
Bondanza, A.3
Ponzoni, M.4
Sanvito, F.5
Aldrighetti, L.6
Radrizzani, M.7
Simona La, S.C.8
Provasi, E.9
Mondino, A.10
Nagasawa, T.11
Fleischhauer, K.12
Russo, V.13
Traversari, C.14
Ciceri, F.15
Bordignon, C.16
Bonini, C.17
-
67
-
-
70350458112
-
Adoptively transferred effector cells derived from nave rather than central memory CD8 + T-cells mediate superior antitumor immunity
-
Hinrichs C. S., Borman Z. A., Cassard L., Gattinoni L., Spolski R., Zhiya Y., Sanchez-Perez L., Muranski P., Kern S. J., Logun C., Palmer D. C., Yun J., Reger R. N., Leonard W. J., Danner R. L., Rosenberg S. A., Restifo N. P., Adoptively transferred effector cells derived from nave rather than central memory CD8 + T-cells mediate superior antitumor immunity Proceedings of the National Academy of Sciences of the United States of America 2009 106 41 17469 17474
-
(2009)
Proceedings of the National Academy of Sciences of the United States of America
, vol.106
, Issue.41
, pp. 17469-17474
-
-
Hinrichs, C.S.1
Borman, Z.A.2
Cassard, L.3
Gattinoni, L.4
Spolski, R.5
Zhiya, Y.6
Sanchez-Perez, L.7
Muranski, P.8
Kern, S.J.9
Logun, C.10
Palmer, D.C.11
Yun, J.12
Reger, R.N.13
Leonard, W.J.14
Danner, R.L.15
Rosenberg, S.A.16
Restifo, N.P.17
-
68
-
-
27644445691
-
+ helper T cells induces potent primary and secondary tumor rejection
-
DOI 10.1182/blood-2004-12-4906
-
Moeller M., Haynes N. M., Kershaw M. H., Jackson J. T., Teng M. W. L., Street S. E., Cerutti L., Jane S. M., Trapani J. A., Smyth M. J., Darcy P. K., Adoptive transfer of gene-engineered CD4 + helper T-cells induces potent primary and secondary tumor rejection Blood 2005 106 9 2995 3003 (Pubitemid 41565891)
-
(2005)
Blood
, vol.106
, Issue.9
, pp. 2995-3003
-
-
Moeller, M.1
Haynes, N.M.2
Kershaw, M.H.3
Jackson, J.T.4
Teng, M.W.L.5
Street, S.E.6
Cerutti, L.7
Jane, S.M.8
Trapani, J.A.9
Smyth, M.J.10
Darcy, P.K.11
-
69
-
-
56249128626
-
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
-
Kruschinski A., Moosmann A., Poschke I., Norell H., Chmielewski M., Seliger B., Kiessling R., Blankenstein T., Abken H., Charo J., Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas Proceedings of the National Academy of Sciences of the United States of America 2008 105 45 17481 17486
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.45
, pp. 17481-17486
-
-
Kruschinski, A.1
Moosmann, A.2
Poschke, I.3
Norell, H.4
Chmielewski, M.5
Seliger, B.6
Kiessling, R.7
Blankenstein, T.8
Abken, H.9
Charo, J.10
-
70
-
-
67549118956
-
Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
-
Boissel L., Betancur M., Wels W. S., Tuncer H., Klingemann H., Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells Leukemia Research 2009 33 9 1255 1259
-
(2009)
Leukemia Research
, vol.33
, Issue.9
, pp. 1255-1259
-
-
Boissel, L.1
Betancur, M.2
Wels, W.S.3
Tuncer, H.4
Klingemann, H.5
-
71
-
-
55249087037
-
Resistance of mature T-cells to oncogene transformation
-
Newrzela S., Cornils K., Li Z., Baum C., Brugman M. H., Hartmann M., Meyer J., Hartmann S., Hansmann M. L., Fehse B., Von Laer D., Resistance of mature T-cells to oncogene transformation Blood 2008 112 6 2278 2286
-
(2008)
Blood
, vol.112
, Issue.6
, pp. 2278-2286
-
-
Newrzela, S.1
Cornils, K.2
Li, Z.3
Baum, C.4
Brugman, M.H.5
Hartmann, M.6
Meyer, J.7
Hartmann, S.8
Hansmann, M.L.9
Fehse, B.10
Von Laer, D.11
-
72
-
-
77953479708
-
Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer
-
Perro M., Tsang J., Xue S. A., Escors D., Cesco-Gaspere M., Pospori C., Gao L., Hart D., Collins M., Stauss H., Morris E. C., Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer Gene Therapy 2010 17 6 721 732
-
(2010)
Gene Therapy
, vol.17
, Issue.6
, pp. 721-732
-
-
Perro, M.1
Tsang, J.2
Xue, S.A.3
Escors, D.4
Cesco-Gaspere, M.5
Pospori, C.6
Gao, L.7
Hart, D.8
Collins, M.9
Stauss, H.10
Morris, E.C.11
-
73
-
-
78549253550
-
Multiple injections of electroporated autologous T-cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor
-
Zhao Y., Moon E., Carpenito C., Paulos C. M., Liu X., Brennan A. L., Chew A., Carroll R. G., Scholler J., Levine B. L., Albelda S. M., June C. H., Multiple injections of electroporated autologous T-cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor Cancer Research 2010 70 22 9053 9061
-
(2010)
Cancer Research
, vol.70
, Issue.22
, pp. 9053-9061
-
-
Zhao, Y.1
Moon, E.2
Carpenito, C.3
Paulos, C.M.4
Liu, X.5
Brennan, A.L.6
Chew, A.7
Carroll, R.G.8
Scholler, J.9
Levine, B.L.10
Albelda, S.M.11
June, C.H.12
-
74
-
-
55549129245
-
Progress and prospects: Zinc-finger nucleases as gene therapy agents
-
Carroll D., Progress and prospects: zinc-finger nucleases as gene therapy agents Gene Therapy 2008 15 22 1463 1468
-
(2008)
Gene Therapy
, vol.15
, Issue.22
, pp. 1463-1468
-
-
Carroll, D.1
-
75
-
-
77956840374
-
Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma
-
Mihara K., Yanagihara K., Takigahira M., Kitanaka A., Imai C., Bhattacharyya J., Kubo T., Takei Y., Yasunaga S., Takihara Y., Kimura A., Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma British Journal of Haematology 2010 151 1 37 46
-
(2010)
British Journal of Haematology
, vol.151
, Issue.1
, pp. 37-46
-
-
Mihara, K.1
Yanagihara, K.2
Takigahira, M.3
Kitanaka, A.4
Imai, C.5
Bhattacharyya, J.6
Kubo, T.7
Takei, Y.8
Yasunaga, S.9
Takihara, Y.10
Kimura, A.11
-
76
-
-
33646440024
-
Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: First clinical experience
-
Lamers C. H. J., Sleijfer S., Vulto A. G., Kruit W. H., Kliffen M., Debets R., Gratama J. W., Stoter G., Oosterwijk E., Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience Journal of Clinical Oncology 2006 24 13 e20 e22
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.13
-
-
Lamers, C.H.J.1
Sleijfer, S.2
Vulto, A.G.3
Kruit, W.H.4
Kliffen, M.5
Debets, R.6
Gratama, J.W.7
Stoter, G.8
Oosterwijk, E.9
-
77
-
-
38649127824
-
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer
-
DOI 10.1073/pnas.0710198105
-
Kieback E., Charo J., Sommermeyer D., Blankenstein T., Uckert W., A safeguard eliminates T-cell receptor gene-modified autoreactive T-cells after adoptive transfer Proceedings of the National Academy of Sciences of the United States of America 2008 105 2 623 628 (Pubitemid 351171758)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.2
, pp. 623-628
-
-
Kieback, E.1
Charo, J.2
Sommermeyer, D.3
Blankenstein, T.4
Uckert, W.5
-
78
-
-
44449114273
-
An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease
-
de Witte M. A., Jorritsma A., Swart E., Straathof K. C., De Punder K., Haanen J. B. A. G., Rooney C. M., Schumacher T. N. M., An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease Journal of Immunology 2008 180 9 6365 6373
-
(2008)
Journal of Immunology
, vol.180
, Issue.9
, pp. 6365-6373
-
-
De Witte, M.A.1
Jorritsma, A.2
Swart, E.3
Straathof, K.C.4
De Punder, K.5
Haanen, J.B.A.G.6
Rooney, C.M.7
Schumacher, T.N.M.8
|